Show items per page
Elements: 74
Page 1 on 4
 TitleAuthors / EditorsDate
add to browser selection
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia Walker, Zuzana; Gandolfo, Federica; Orini, Stefania; Garibotto, Valentina; ... Nobili, Flavio 2018
add to browser selection
A comparison of automated segmentation and manual tracing in estimating hippocampal volume in ischemic stroke and healthy control participants Khlif, Mohamed Salah; Egorova, Natalia; Werden, Emilio; Redolfi, Alberto; ... Brodtmann, Amy 2018
add to browser selection
Abnormalities in functional connectivity in borderline personality disorder: Correlations with metacognition and emotion dysregulation Quattrini, Giulia; Pini, Lorenzo; Pievani, Michela; Magni, Laura R; ... Rossi, Roberta 2018
add to browser selection
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease Drzezga, Alexander; Altomare, Daniele; Festari, Cristina; Arbizu, Javier; ... Boccardi, Marina 2018
add to browser selection
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia Bouwman, Femke; Orini, Stefania; Gandolfo, Federica; Altomare, Daniele; ... Boccardi, Marina 2018
add to browser selection
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia Nestor, Peter J; Altomare, Daniele; Festari, Cristina; Drzezga, Alexander; ... Frisoni, Giovanni 2018
add to browser selection
Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders Nobili, Flavio; Festari, Cristina; Altomare, Daniele; Agosta, Federica; ... Boccardi, Marina 2018
add to browser selection
Clinical utility of FDG-PET in amyotrophic lateral sclerosis and Huntington's disease Agosta, Federica; Altomare, Daniele; Festari, Cristina; Orini, Stefania; ... Pagani, Marco 2018
add to browser selection
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia Boccardi, Marina; Festari, Cristina; Altomare, Daniele; Gandolfo, Federica; ... Frisoni, Giovanni 2018
add to browser selection
Clinical utility of FDG-PET for the clinical diagnosis in MCI Arbizu, Javier; Festari, Cristina; Altomare, Daniele; Walker, Zuzana; ... Nobili, Flavio 2018
add to browser selection
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET Altomare, Daniele; Ferrari, Clarissa; Festari, Cristina; Guerra, Ugo Paolo; ... Boccardi, Marina 2018
add to browser selection
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus Nobili, F; Arbizu, J; Bouwman, F; Drzezga, A; ... Boccardi, Marina 2018
add to browser selection
L’atrophie du lobe temporal mésial détectée par IRM en tant que biomarqueur de la maladie d’Alzheimer Elsiddig, Aliaa Ahmed Ibnidris; Grosu, Claire Julie; Ferrer Soler, Cecilia; Scheffler, Max; ... Frisoni, Giovanni 2018
add to browser selection
Biomarkers for the diagnosis of Alzheimer's disease in clinical practice: an Italian intersocietal roadmap Frisoni, Giovanni; Perani, Daniela; Bastianello, Stefano; Bernardi, Gaetano; ... Padovani, Alessandro 2017
add to browser selection
Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework Ten Kate, Mara; Barkhof, Frederik; Boccardi, Marina; Visser, Pieter Jelle; ... Scheltens, Philip 2017
add to browser selection
The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncology Boccardi, Marina; Gallo, Valentina; Yasui, Yutaka; Vineis, Paolo; ... Albanese, Emiliano 2017
add to browser selection
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework Garibotto, Valentina; Herholz, Karl; Boccardi, Marina; Picco, Agnese; ... Ratib, Osman 2017
add to browser selection
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework Chiotis, Konstantinos; Saint-Aubert, Laure; Boccardi, Marina; Gietl, Anton; ... Nordberg, Agneta 2017
add to browser selection
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers Frisoni, Giovanni; Boccardi, Marina; Garibotto, Valentina; Giannakopoulos, Panteleimon; ... Ratib, Osman 2017
add to browser selection
Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry Wolf, Dominik; Bocchetta, Martina; Preboske, Gregory M; Boccardi, Marina; Grothe, Michel J 2017
<< previous | 1 | 2 | 3 | 4 |